Depression News and Research

Latest Depression News and Research

U.S. aid to Afghanistan unlikely to produce lasting change, congressional report says

"Much of the $19 billion in foreign aid that the United States has pumped into Afghanistan in the past decade may be fueling development on the ground in the short term, but is unlikely to produce change that will last once U.S. troops depart, according to a new congressional report," the Christian Science Monitor reports.

10 Jun 2011

Smoking keeps weight off: Study finds out how

The researchers have found that nicotine activates a pathway in the brain that suppresses appetite. The study was published in the journal Science. The authors believe this discovery should lead to better diet drugs.

9 Jun 2011

Social, physical and spiritual activities can improve quality of life in older individuals

Small, healthy lifestyle changes and involvement in meaningful activities-going beyond just diet and exercise-are critical to healthy aging, according to a new USC study.

9 Jun 2011

Neurologix reports new results from NLX-P101 Phase 2 trial against Parkinson's disease

Neurologix, Inc. announced today several new results from the Company's successful Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease (PD) as part of a comprehensive presentation of study findings to the National Institutes of Health (NIH) Recombinant DNA Advisory Committee.

9 Jun 2011

Paladin to commercialize Silenor for treatment of insomnia in Canada, South America and Africa

Somaxon Pharmaceuticals, Inc. and Paladin Labs Inc. today announced that they have entered into an exclusive collaboration under which Paladin will commercialize Silenor® (doxepin) for the treatment of insomnia characterized by difficulty with sleep maintenance in Canada, South America and Africa.

8 Jun 2011

Articles on health trajectories now available in Nursing Research journal

Health care research typically focuses on final outcomes such as cure or death—overlooking the fact that health and illness are dynamic states that evolve and change over time. A special collection of articles on health trajectory research is now available in a supplement to Nursing Research, official journal of the Eastern Nursing Research Society and the Western Institute of Nursing.

8 Jun 2011

New neurons may take over six months to mature

New neurons take more than six months to mature in adult monkeys and that time is likely even longer in humans, according to researchers at the University of Pittsburgh School of Medicine, the University of Illinois, and Pennsylvania State University.

8 Jun 2011

SPI and Neuralstem sign licensing agreement for major depression drug, NSI-189

Neuralstem, Inc. announced that it has signed an exclusive agency licensing agreement with Summit Pharmaceuticals International Corporation, of Tokyo, Japan (SPI), a wholly owned subsidiary of Sumitomo Corporation Group.

8 Jun 2011

EC approves Biogen Idec's AVONEX PEN to treat multiple sclerosis

Biogen Idec announced today that the European Commission (EC) has granted approval to AVONEX PEN for patients with relapsing multiple sclerosis (MS) and patients who have had a single demyelinating event.

7 Jun 2011

Women with higher leptin levels have fewer symptoms of depression

Women who have higher levels of the appetite-controlling hormone leptin have fewer symptoms of depression, and this apparent inverse relationship is not related to body mass index (BMI), a new study finds.

7 Jun 2011

Homelessness and mental illness link explored in RMIT study

In a new study by the RMIT University, Victoria researchers looked at cases of 4,291 people using homelessness services in the city. Dr Guy Johnson and Professor Chris Chamberlain found almost half of them - 46 per cent - lost their homes after a family breakdown. This is contrary to the long held belief that most homeless people are mentally unstable.

7 Jun 2011

Dr. Reddy’s launches generic ARICEPT, EFFEXOR XR and FEMARA in the US

Dr. Reddy's Laboratories today announced that it has launched three products in the US market.

6 Jun 2011

Ganeden Biotech sells Sustenex and Digestive Advantage to Schiff for $40 million

Ganeden Biotech announced the sale of its leading Sustenex® and Digestive Advantage® brands of probiotic dietary supplements to Schiff Nutrition International, Inc. for $40 million in cash. Ganeden will also receive royalties on Schiff products containing GanedenBC30™.

6 Jun 2011

Positive data from Biogen Idec's AVONEX clinical trial on multiple sclerosis presented at CMSC 2011

Biogen Idec today announced the findings from a randomized, multicenter, dose-blinded clinical trial that evaluated the effect of AVONEX dose titration, or gradual dose escalation, on flu-like symptoms associated with the therapy.

6 Jun 2011

Researchers discover a peptide that short circuits chronic pain pathway

Researchers at the Indiana University School of Medicine have discovered a peptide that short circuits a pathway for chronic pain. Unlike current treatments this peptide does not exhibit deleterious side effects such as reduced motor coordination, memory loss, or depression, according to an article in Nature Medicine posted online June 5, 2011.

6 Jun 2011

GP journal focuses on mental health

Australian Family Physician, the flagship journal of The Royal Australian College of General Practitioners (RACGP), features a range of clinical, viewpoint and research articles focusing on key issues in general practice today. The June 2011 edition focuses on mental illness and includes the following feature articles.

6 Jun 2011

Results from HSPPC-96 Phase 2 study against recurrent gliobastoma presented at ASCO 2011

In data presented at The American Society of Clinical Oncology (ASCO) Annual Meeting, cancer researchers found that the brain tumor vaccine HSPPC-96 for treating recurrent gliobastoma (GBM) has a favorable safety profile and extends survival by two to three times more than the current median survival rate.

4 Jun 2011

Five years after cancer treatment, many survivors still suffer symptoms

When people finish treatment for cancer, they want to bounce back to their former vital selves as quickly as possible. But a new Northwestern Medicine study -- one of the largest survivor studies ever conducted - shows many survivors still suffer moderate to severe problems with pain, fatigue, sleep, memory and concentration three to five years after treatment has ended.

4 Jun 2011

Research roundup: More spending can lead to better care; Calif. exchange lessons; high-volume hospitals

Medical Spending And The Health Of The Elderly -- Does more medical spending lead to better health care for people over age 64? To answer that question, "researchers from George Mason University and the Urban Institute used data of 17,438 elderly who entered the Medicare Current Beneficiary Survey in the fall of each year from 1991 to 1999, and conducted multiple interviews over three years," according to one description of the study.

4 Jun 2011

Cyberonics net sales increase 14% to $190.5 million for fiscal 2011

Cyberonics, Inc., a global leader in epilepsy management, today announced results for the fourth quarter and fiscal year ended April 29, 2011.

2 Jun 2011

Depression News and Research

Latest Depression News and Research

U.S. aid to Afghanistan unlikely to produce lasting change, congressional report says

Smoking keeps weight off: Study finds out how

Social, physical and spiritual activities can improve quality of life in older individuals

Neurologix reports new results from NLX-P101 Phase 2 trial against Parkinson's disease

Paladin to commercialize Silenor for treatment of insomnia in Canada, South America and Africa

Articles on health trajectories now available in Nursing Research journal

New neurons may take over six months to mature

SPI and Neuralstem sign licensing agreement for major depression drug, NSI-189

EC approves Biogen Idec's AVONEX PEN to treat multiple sclerosis

Women with higher leptin levels have fewer symptoms of depression

Homelessness and mental illness link explored in RMIT study

Dr. Reddy’s launches generic ARICEPT, EFFEXOR XR and FEMARA in the US

Ganeden Biotech sells Sustenex and Digestive Advantage to Schiff for $40 million

Positive data from Biogen Idec's AVONEX clinical trial on multiple sclerosis presented at CMSC 2011

Researchers discover a peptide that short circuits chronic pain pathway

GP journal focuses on mental health

Results from HSPPC-96 Phase 2 study against recurrent gliobastoma presented at ASCO 2011

Five years after cancer treatment, many survivors still suffer symptoms

Research roundup: More spending can lead to better care; Calif. exchange lessons; high-volume hospitals

Cyberonics net sales increase 14% to $190.5 million for fiscal 2011

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Depression News and Research

Latest Depression News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in